Article Details

Imbria Pharmaceuticals Announces Initiation of Enrollment in IMPROVE-HCM, a Phase 2 Study ...

Retrieved on: 2021-07-19 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Imbria Pharmaceuticals Announces Initiation of Enrollment in IMPROVE-HCM, a Phase 2 Study .... View article details on hiswai:

Excerpt

INDUSTRY KEYWORD: RESEARCH GENETICS CLINICAL TRIALS CARDIOLOGY ... HEALTH PHARMACEUTICAL GENERAL HEALTH SCIENCE.

Article found on: www.galvnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up